Can Darzalex (daratumumab) therapy interfere with response assessment?

 

In this week’s video, Dr. Brian GM Durie explains how to determine if monoclonal protein spikes in the blood are actually spikes due to daratumumab therapy.

BOTTOM LINE:

When assessing response, ensure that a monoclonal protein spike is not a dara spike with the proper tests.

Have a question? Submit it to AskDrDurie@myeloma.org

IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to askdrdurie@myeloma.org!

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at infoline@myeloma.org